Copyright Reports & Markets. All rights reserved.

Global Hydrocortisone

Buy now

Table of Contents

    2019-2024 Global Hydrocortisone Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Hydrocortisone Market Size 2014-2024
        • 2.1.2 Hydrocortisone Market Size CAGR by Region
      • 2.2 Hydrocortisone Segment by Type
        • 2.2.1 Cream
        • 2.2.2 Injection
        • 2.2.3 Table
      • 2.3 Hydrocortisone Market Size by Type
        • 2.3.1 Global Hydrocortisone Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Hydrocortisone Market Size Growth Rate by Type (2014-2019)
      • 2.4 Hydrocortisone Segment by Application
        • 2.4.1 Adrenocortical Dysfunction
        • 2.4.2 Adrenergic Syndrome
        • 2.4.3 High Blood Calcium
        • 2.4.4 Thyroiditis
        • 2.4.5 Rheumatoid Arthritis
        • 2.4.6 Dermatitis
        • 2.4.7 Asthma and Chronic Obstructive Pulmonary Disease
        • 2.4.8 Other
      • 2.5 Hydrocortisone Market Size by Application
        • 2.5.1 Global Hydrocortisone Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Hydrocortisone Market Size Growth Rate by Application (2014-2019)

      3 Global Hydrocortisone by Players

      • 3.1 Global Hydrocortisone Market Size Market Share by Players
        • 3.1.1 Global Hydrocortisone Market Size by Players (2017-2019)
        • 3.1.2 Global Hydrocortisone Market Size Market Share by Players (2017-2019)
      • 3.2 Global Hydrocortisone Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Hydrocortisone by Regions

      • 4.1 Hydrocortisone Market Size by Regions
      • 4.2 Americas Hydrocortisone Market Size Growth
      • 4.3 APAC Hydrocortisone Market Size Growth
      • 4.4 Europe Hydrocortisone Market Size Growth
      • 4.5 Middle East & Africa Hydrocortisone Market Size Growth

      5 Americas

      • 5.1 Americas Hydrocortisone Market Size by Countries
      • 5.2 Americas Hydrocortisone Market Size by Type
      • 5.3 Americas Hydrocortisone Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Hydrocortisone Market Size by Countries
      • 6.2 APAC Hydrocortisone Market Size by Type
      • 6.3 APAC Hydrocortisone Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Hydrocortisone by Countries
      • 7.2 Europe Hydrocortisone Market Size by Type
      • 7.3 Europe Hydrocortisone Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Hydrocortisone by Countries
      • 8.2 Middle East & Africa Hydrocortisone Market Size by Type
      • 8.3 Middle East & Africa Hydrocortisone Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Hydrocortisone Market Forecast

      • 10.1 Global Hydrocortisone Market Size Forecast (2019-2024)
      • 10.2 Global Hydrocortisone Forecast by Regions
        • 10.2.1 Global Hydrocortisone Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Hydrocortisone Forecast by Type
      • 10.8 Global Hydrocortisone Forecast by Application

      11 Key Players Analysis

      • 11.1 Pfizer
        • 11.1.1 Company Details
        • 11.1.2 Hydrocortisone Product Offered
        • 11.1.3 Pfizer Hydrocortisone Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Pfizer News
      • 11.2 Sanofi
        • 11.2.1 Company Details
        • 11.2.2 Hydrocortisone Product Offered
        • 11.2.3 Sanofi Hydrocortisone Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Sanofi News
      • 11.3 Teva
        • 11.3.1 Company Details
        • 11.3.2 Hydrocortisone Product Offered
        • 11.3.3 Teva Hydrocortisone Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Teva News
      • 11.4 Akorn
        • 11.4.1 Company Details
        • 11.4.2 Hydrocortisone Product Offered
        • 11.4.3 Akorn Hydrocortisone Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Akorn News
      • 11.5 GSK
        • 11.5.1 Company Details
        • 11.5.2 Hydrocortisone Product Offered
        • 11.5.3 GSK Hydrocortisone Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 GSK News
      • 11.6 Bausch and Lomb
        • 11.6.1 Company Details
        • 11.6.2 Hydrocortisone Product Offered
        • 11.6.3 Bausch and Lomb Hydrocortisone Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Bausch and Lomb News
      • 11.7 Bayer Pharmas
        • 11.7.1 Company Details
        • 11.7.2 Hydrocortisone Product Offered
        • 11.7.3 Bayer Pharmas Hydrocortisone Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Bayer Pharmas News
      • 11.8 Macleods Pharmaceuticals
        • 11.8.1 Company Details
        • 11.8.2 Hydrocortisone Product Offered
        • 11.8.3 Macleods Pharmaceuticals Hydrocortisone Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Macleods Pharmaceuticals News
      • 11.9 Casper Pharma
        • 11.9.1 Company Details
        • 11.9.2 Hydrocortisone Product Offered
        • 11.9.3 Casper Pharma Hydrocortisone Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 Casper Pharma News
      • 11.10 Dow Pharma
        • 11.10.1 Company Details
        • 11.10.2 Hydrocortisone Product Offered
        • 11.10.3 Dow Pharma Hydrocortisone Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 Dow Pharma News
      • 11.11 Fougera Pharms
      • 11.12 Hikma Intl Pharms
      • 11.13 Impax Labs
      • 11.14 Ivax Pharms
      • 11.15 Lannett
      • 11.16 Merck
      • 11.17 Novartis
      • 11.18 Salix Pharms
      • 11.19 Sandoz
      • 11.20 TARO
      • 11.21 Valeant
      • 11.22 Wockhardt
      • 11.23 Farmak JSC
      • 11.24 Solvay Pharma
      • 11.25 Alcon
      • 11.26 Paladin Labs
      • 11.27 Adcock Ingram
      • 11.28 ADARE Pharmaceuticals
      • 11.29 Aspen Holdings
      • 11.30 Astellas Pharma

      12 Research Findings and Conclusion

      According to this study, over the next five years the Hydrocortisone market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Hydrocortisone business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares and growth opportunities of Hydrocortisone market by product type, application, key companies and key regions.

      This study considers the Hydrocortisone value generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
      Cream
      Injection
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
      Adrenocortical Dysfunction
      Adrenergic Syndrome
      High Blood Calcium
      Thyroiditis
      Rheumatoid Arthritis
      Dermatitis
      Asthma and Chronic Obstructive Pulmonary Disease
      Other

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Pfizer
      Sanofi
      Teva
      Akorn
      GSK
      Bausch and Lomb
      Bayer Pharmas
      Macleods Pharmaceuticals
      Casper Pharma
      Dow Pharma
      Fougera Pharms
      Hikma Intl Pharms
      Impax Labs
      Ivax Pharms
      Lannett
      Merck
      Novartis
      Salix Pharms
      Sandoz
      TARO
      Valeant
      Wockhardt
      Farmak JSC
      Solvay Pharma
      Alcon
      Paladin Labs
      Adcock Ingram
      ADARE Pharmaceuticals
      Aspen Holdings
      Astellas Pharma

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Hydrocortisone market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Hydrocortisone market by identifying its various subsegments.
      Focuses on the key global Hydrocortisone players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Hydrocortisone with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of Hydrocortisone submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now